Provider: NIHR Journals Library
Content:text/plain; charset="UTF-8"
TY  - JOUR
LB  - 1.
AU  - Wiselka, M
TI  - Influenza: diagnosis, management and prophylaxis
J2  - BMJ
PY  - 1994
VL  - 308
SP  - 1341
EP  - 1345
ER  - 
TY  - CHAP
LB  - 2.
AU  - Nicholson, KG
TI  - Human influenza
A2  - Nicholson, KG
A2  - Webster, RG
A2  - Hay, AJ
T2  - Textbook of influenza
CY  - Oxford
PB  - Blackwell Science
PY  - 1998
SP  - 219
EP  - 264
ER  - 
TY  - JOUR
LB  - 3.
AU  - Tillett, HE
AU  - Smith, JWG
AU  - Gooch, CD
TI  - Excess deaths attributable to influenza in England and Wales: age at death and certified cause
J2  - Int J Epidemiol
PY  - 1983
VL  - 12
SP  - 344
EP  - 352
ER  - 
TY  - JOUR
LB  - 4.
AU  - Nicholson, KG
TI  - Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990
J2  - Epidemiol Infect
PY  - 1996
VL  - 116
SP  - 51
EP  - 63
ER  - 
TY  - JOUR
LB  - 5.
AU  - Fleming, DM
TI  - The contribution of influenza to combined acute respiratory infections, hospital admissions and deaths in winter
J2  - Commun Dis Publ Health
PY  - 2000
VL  - 3
SP  - 32
EP  - 38
ER  - 
TY  - CHAP
LB  - 6.
AU  - Ruigrok, RWH
TI  - Structure of influenza A, B and C viruses
A2  - Nicholson, KG
A2  - Webster, RG
A2  - Hay, AJ
T2  - Textbook of influenza
CY  - Oxford
PB  - Blackwell Science
PY  - 1998
SP  - 29
EP  - 42
ER  - 
TY  - CHAP
LB  - 7.
AU  - Jefferson, T
AU  - Demicheli, V
TI  - Socioeconomics of influenza
A2  - Nicholson, KG
A2  - Webster, RG
A2  - Hay, AJ
T2  - Textbook of influenza
CY  - Oxford
PB  - Blackwell Science
PY  - 1998
SP  - 541
EP  - 547
ER  - 
TY  - ELEC
LB  - 8.
AU  - Health Protection Agency (HPA)
UR  - www.hpa.org.uk/infections/topics_az/influenza/seasonal/default.htm
PY  - 2007
ER  - 
TY  - JOUR
LB  - 9.
AU  - Douglas, RG
TI  - Prophylaxis and treatment of influenza
J2  - New Engl J Med
PY  - 1990
VL  - 322
SP  - 443
EP  - 450
ER  - 
TY  - JOUR
LB  - 10.
AU  - Turner, D
AU  - Wailoo, A
AU  - Nicholson, K
AU  - Cooper, N
AU  - Sutton,, A
AU  - Abrams, K
TI  - Systematic review and economic decision modelling for the prevention and treatment of influenza A and B
J2  - Health Technol Assess
PY  - 2003
VL  - 7
SP  - 1
EP  - 170
ER  - 
TY  - GEN
LB  - 11.
AU  - Health Protection Agency (HPA) Centre for Infections (CfI)
TI  - HPA national influenza season summary 2006/2007
PY  - 2007
ER  - 
TY  - JOUR
LB  - 12.
AU  - Meier, CR
AU  - Napalkov, PN
AU  - Wegmuller, Y
AU  - Jefferson, T
AU  - Jick, H
TI  - Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom
J2  - Eur J Clin Microbiol Infect Dis
PY  - 2000
VL  - 19
SP  - 834
EP  - 842
ER  - 
TY  - JOUR
LB  - 13.
AU  - Nicholson, KG
AU  - Wood, JM
AU  - Zambon, M
TI  - Influenza
J2  - Lancet
PY  - 2003
VL  - 362
SP  - 1733
EP  - 1745
ER  - 
TY  - GEN
LB  - 14.
AU  - British Medical Association and Royal Pharmaceutical Society of Great Britain
TI  - British national formulary
SP  - 54
PY  - 2007
ER  - 
TY  - GEN
LB  - 15.
AU  - Department of Health Immunisation programme for poultry workers
TI  - Guidance on the implementation of a seasonal flu vaccination programme for poultry workers
PY  - 2007
ER  - 
TY  - GEN
LB  - 16.
AU  - National Institute for Clinical Excellence
TI  - Guidance on the use of oseltamivir and amantadine for the prophylaxis of influenza
PY  - 2003
ER  - 
TY  - GEN
LB  - 17.
AU  - NHS and National Institute for Clinical Excellence
TI  - Guidance on the use of zanamivir, oseltamivir and amantadine for the treatment of influenza
PY  - 2003
ER  - 
TY  - GEN
LB  - 18.
AU  - Joint Formulary Committee
TI  - British national formulary
PY  - 2007
ER  - 
TY  - GEN
LB  - 19.
AU  - Department of Health
TI  - The influenza immunisation programme 2007/2008
PY  - 2007
ER  - 
TY  - GEN
LB  - 20.
AU  - Roche
TI  - Tamiflu (oseltamivir) influenza prophylaxis: achieving clinical excellence in influenza prophylaxis
PY  - 2007
SP  - 1
EP  - 197
ER  - 
TY  - JOUR
LB  - 21.
AU  - Monto, AS
AU  - McKimm-Breschkin, JL
AU  - Macken, C
AU  - Hampson, AW
AU  - Hay, A
AU  - Klimov, A
TI  - Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
J2  - Antimicrob Agents Chemother
PY  - 2006
VL  - 50
SP  - 2395
EP  - 2402
ER  - 
TY  - GEN
LB  - 22.
AU  - Department of Health
TI  - National Service Framework for Older People
PY  - 2001
ER  - 
TY  - GEN
LB  - 23.
AU  - Department of Health
TI  - National Service Framework for Coronary Heart Disease
PY  - 2000
ER  - 
TY  - JOUR
LB  - 24.
AU  - Alliance Pharmaceuticals
TI  - Lysovir 100 mg capsules
J2  - Summary of product characteristics
PY  - 2005
ER  - 
TY  - JOUR
LB  - 25.
AU  - Roche
TI  - Tamiflu 12 mg/ml powder for oral suspension
J2  - Summary of product characteristics
PY  - 2007
ER  - 
TY  - JOUR
LB  - 26.
AU  - Roche
TI  - Tamiflu 30 mg hard capsules
J2  - Summary of product characteristics
PY  - 2007
ER  - 
TY  - JOUR
LB  - 27.
AU  - Roche
TI  - Tamiflu 45 mg hard capsules
J2  - Summary of product characteristics
PY  - 2007
ER  - 
TY  - JOUR
LB  - 28.
AU  - Roche
TI  - Tamiflu 75 mg hard capsules
J2  - Summary of Product Characteristics
PY  - 2007
ER  - 
TY  - JOUR
LB  - 29.
AU  - GlaxoSmithKline
TI  - Relenza 5 mg/dose inhalation powder
J2  - Summary of product characteristics
PY  - 2006
ER  - 
TY  - CHAP
LB  - 30.
AU  - Aoki, F
TI  - Amantadine and rimantadine
A2  - Nicholson, KG
A2  - Webster, RG
A2  - Hay, AJ
T2  - Textbook of influenza
CY  - Oxford
PB  - Blackwell Science
PY  - 1998
SP  - 457
EP  - 476
ER  - 
TY  - JOUR
LB  - 31.
AU  - Hayden, FG
TI  - Antiviral resistance in influenza viruses – implications for management and pandemic response
J2  - New Engl J Med
PY  - 2006
VL  - 354
SP  - 785
EP  - 788
ER  - 
TY  - JOUR
LB  - 32.
AU  - Schilling, M
AU  - Gravenstein, S
AU  - Drinka, P
AU  - Cox, N
AU  - Krause, P
AU  - Povinelli, L
TI  - Emergence and transmission of amantadine-resistant influenza A in a nursing home
J2  - J Am Geriatr Soc
PY  - 2004
VL  - 52
SP  - 2069
EP  - 2073
ER  - 
TY  - GEN
LB  - 33.
AU  - Jefferson, T
AU  - Demicheli, V
AU  - Di Pietrantonj, C
AU  - Rivetti, D
TI  - Amantadine and rimantadine for influenza A in adults
PY  - 2006
ER  - 
TY  - CHAP
LB  - 34.
AU  - Penn, C
TI  - Inhibitors of influenza virus neuraminidase
A2  - Nicholson, KG
A2  - Webster, RG
A2  - Hay, AJ
T2  - Textbook of influenza
CY  - Oxford
PB  - Blackwell Science
PY  - 1998
SP  - 477
EP  - 487
ER  - 
TY  - JOUR
LB  - 35.
AU  - Moher, D
AU  - Cook, DJ
AU  - Eastwood, S
AU  - Olkin, I
AU  - Rennie, D
AU  - Stroup, DF
TI  - and for the QUOROM Group. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement
J2  - Lancet
PY  - 1999
VL  - 354
SP  - 1896
EP  - 1900
ER  - 
TY  - GEN
LB  - 36.
AU  - NHS Centre for Reviews and Dissemination
TI  - Report 4: undertaking systematic reviews on effectiveness; CRDs guidance for those carrying out or commissioning reviews
PY  - 2001
ER  - 
TY  - JOUR
LB  - 37.
AU  - Hess, P
TI  - Amantadine and rimantadine in the prophylaxis of influenza A
J2  - Med Hygiene
PY  - 1982
VL  - 40
SP  - 3496
ER  - 
TY  - JOUR
LB  - 38.
AU  - Plesnik, V
AU  - Heinz, F
AU  - Bindas, B
AU  - Cechova, D
AU  - Eliasova, J
AU  - Galetkova, A
TI  - Controlled study of influenza prophylaxis by VUFB amantadin
J2  - Cesk Epidemiol Mikrobiol Imunol
PY  - 1977
VL  - 26
SP  - 216
EP  - 226
ER  - 
TY  - JOUR
LB  - 39.
AU  - Quilligan, JJ, Jr
AU  - Hirayama, M
AU  - Baernstein, HD, Jr
TI  - The prevention of A2-influenza in children by chemoprophylaxis with amantadine hydrochloride
J2  - J Suisse Med
PY  - 1966
VL  - 96
SP  - 1689
EP  - 1692
ER  - 
TY  - JOUR
LB  - 40.
AU  - Smorodintsev, AA
AU  - Romanov, YA
AU  - Rumovski, VI
AU  - Zlydniko, DM
TI  - Effectiveness of hydrochloric amantadine (midantane) in prevention of artificially induced influenza infection
J2  - Vopr Virusol
PY  - 1972
SP  - 152
EP  - 156
ER  - 
TY  - JOUR
LB  - 41.
AU  - Kashiwagi, S
AU  - Kudoh, S
AU  - Watanabe, A
AU  - Yoshimura, I
TI  - Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza – placebo-controlled double-blind multicenter phase III trial
J2  - Kansenshogaku zasshi (Journal of the Japanese Association for Infectious Diseases)
PY  - 2000
VL  - 74
SP  - 1062
EP  - 1076
ER  - 
TY  - JOUR
LB  - 42.
AU  - Shinjoh, M
AU  - Sato, S
AU  - Sugaya, N
AU  - Mitamura, K
AU  - Takeuchi, Y
AU  - Kosaki, K
TI  - Effect of post-exposure prophylaxis with oseltamivir for those in contacts with influenza patients in pediatric wards
J2  - Kansenshogaku Zasshi (Journal of the Japanese Association for Infectious Diseases)
PY  - 2004
VL  - 78
SP  - 262
EP  - 269
ER  - 
TY  - JOUR
LB  - 43.
AU  - Diaz-Pedroche, C
AU  - Lizasoain, M
AU  - Lopez-Medrano, F
AU  - Escalante, F
AU  - Lumbreras, C
AU  - Folgueira, D
TI  - Nosocomial outbreak of influenza in high-risk hematological patients. Efficacy of control measures and the use of zanamivir
J2  - Enferm Infecc Microbiol Clin
PY  - 2006
VL  - 24
SP  - 10
EP  - 13
ER  - 
TY  - GEN
LB  - 44.
AU  - GlaxoSmithKline Pharmaceuticals
TI  - Drugs for the prophylaxis of influenza – review of zanamivir
PB  - Submission to the National Institute for Health and Clinical Excellence
PY  - 2007
ER  - 
TY  - JOUR
LB  - 45.
AU  - Halloran, M
AU  - Hayden, FG
AU  - Yang, Y
AU  - Longini, IM
AU  - Monto, AS
TI  - Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials
J2  - Am J Epidemiol
PY  - 2007
VL  - 165
SP  - 212
EP  - 221
ER  - 
TY  - JOUR
LB  - 46.
AU  - Hayden, FG
AU  - Gubareva, LV
AU  - Monto, AS
AU  - Klein, TC
AU  - Elliott, MJ
AU  - Hammond, JM
TI  - Inhaled zanamivir for the prevention of influenza in families
J2  - New Engl J Med
PY  - 2000
VL  - 343
SP  - 1282
EP  - 1289
ER  - 
TY  - JOUR
LB  - 47.
AU  - Monto, AS
AU  - Pichichero, ME
AU  - Blanckenberg, SJ
AU  - Ruuskanen, O
AU  - Cooper, C
AU  - Fleming, DM
TI  - Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households
J2  - J Infect Dis
PY  - 2002
VL  - 186
SP  - 1582
EP  - 1588
ER  - 
TY  - JOUR
LB  - 48.
AU  - Hayden, FG
AU  - Belshe, R
AU  - Villanueva, C
AU  - Lanno, R
AU  - Hughes, C
AU  - Small, I
TI  - Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis
J2  - J Infect Dis
PY  - 2004
VL  - 189
SP  - 440
EP  - 449
ER  - 
TY  - JOUR
LB  - 49.
AU  - Welliver, R
AU  - Monto, AS
AU  - Carewicz, O
AU  - Schatteman, E
AU  - Hassman, M
AU  - Hedrick, J
TI  - Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial
J2  - JAMA
PY  - 2001
VL  - 285
SP  - 748
EP  - 754
ER  - 
TY  - BOOK
LB  - 50.
AU  - Jefferson, TO
AU  - Demicheli, V
AU  - Deeks, JJ
AU  - Rivetti, D
TI  - Amantadine and rimantadine for preventing and treating influenza A in adults
PB  - Cochrane Database of Systematic Reviews
PY  - 2000
VL  - 2
ER  - 
TY  - JOUR
LB  - 51.
AU  - Finklea, JF
AU  - Hennessy, AV
AU  - Davenport, FM
TI  - A field trial of amantadine prophylaxis in naturally-occurring acute respiratory illness
J2  - Am J Epidemiol
PY  - 1967
VL  - 85
SP  - 403
EP  - 412
ER  - 
TY  - JOUR
LB  - 52.
AU  - Quilligan, JJ
AU  - Hirayama, M
AU  - Baernstein, HD
TI  - The suppression of A2 influenza in children by the chemoprophylactic use of amantadine
J2  - J Pediatr
PY  - 1966
VL  - 69
SP  - 572
EP  - 575
ER  - 
TY  - JOUR
LB  - 53.
AU  - Leung, P
AU  - McIntosh, K
AU  - Chai, H
TI  - Amantadine prophylaxis against influenza A/USSR in children with chronic asthma
J2  - J Allergy Clin Immunol
PY  - 1979
VL  - 63
SP  - 140
ER  - 
TY  - JOUR
LB  - 54.
AU  - Wright, PF
AU  - Khaw, KT
AU  - Oxman, MN
AU  - Shwachman, H
TI  - Evaluation of the safety of amantadine-HC1 and the role of respiratory viral infections in children with cystic fibrosis
J2  - J Infect Dis
PY  - 1976
VL  - 134
SP  - 144
EP  - 149
ER  - 
TY  - JOUR
LB  - 55.
AU  - Pettersson, RF
AU  - Hellström, PE
AU  - Penttinen, K
AU  - Pyhälä, R
AU  - Tokola, O
AU  - Vartio, T
TI  - Evaluation of amantadine in the prophylaxis of influenza A (H1N1) virus infection: a controlled field trial among young adults and high-risk patients
J2  - J Infect Dis
PY  - 1980
VL  - 142
SP  - 377
EP  - 383
ER  - 
TY  - JOUR
LB  - 56.
AU  - Leeming, JT
TI  - Amantidine hydrochloride and the elderly
J2  - BMJ
PY  - 1969
VL  - 1
SP  - 313
EP  - 314
ER  - 
TY  - JOUR
LB  - 57.
AU  - Reuman, PD
AU  - Bernstein, DI
AU  - Keefer, MC
AU  - Young, EC
AU  - Sherwood, JR
AU  - Schiff, GM
TI  - Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A
J2  - Antiviral Res
PY  - 1989
VL  - 11
SP  - 27
EP  - 40
ER  - 
TY  - JOUR
LB  - 58.
AU  - Aoki, FY
AU  - Stiver, HG
AU  - Sitar, DS
AU  - Hammond, GW
AU  - Milley, EV
AU  - Vermeersch, C
TI  - Potential of influenza vaccine and amantadine to prevent influenza A illness in Canadian forces personnel 1980–1983
J2  - Mil Med
PY  - 1986
VL  - 151
SP  - 459
EP  - 465
ER  - 
TY  - JOUR
LB  - 59.
AU  - Payler, DK
AU  - Purdham, PA
TI  - Influenza A prophylaxis with amantadine in a boarding school
J2  - Lancet
PY  - 1984
VL  - 1
SP  - 502
EP  - 504
ER  - 
TY  - JOUR
LB  - 60.
AU  - Smorodintsev, A
AU  - Karpuchin, G
AU  - Zlydnikov, D
TI  - The prospect of amantadine for prevention of influenza A in humans (effectiveness of amantadine during influenza A2/Hong Kong epidemics in January–February 1969 in Leningrad)
J2  - Ann N Y Acad Sci
PY  - 1970
VL  - 173
SP  - 44
EP  - 73
ER  - 
TY  - JOUR
LB  - 61.
AU  - Smorodintsev, AA
AU  - Karapuhi, GI
AU  - Zlydniko, DM
AU  - Malyseva, AM
AU  - Svecova, EG
AU  - Burov, SA
TI  - Prophylactic effectiveness of amantadine hydrochloride in an epidemic of Hong-Kong influenza in Leningrad in 1969
J2  - Bull World Health Organ
PY  - 1970
VL  - 42
SP  - 865
EP  - 872
ER  - 
TY  - JOUR
LB  - 62.
AU  - Smorodintsev, AA
AU  - Zlydnikov, DM
AU  - Kiseleva, AM
AU  - Romanov, JA
AU  - Kazantsev, AP
AU  - Rumovsky, VI
TI  - Evaluation of amantadine in artificially induced A2 and B influenza
J2  - JAMA
PY  - 1970
VL  - 213
SP  - 1448
EP  - 1454
ER  - 
TY  - JOUR
LB  - 63.
AU  - Sears, SD
AU  - Clements, ML
TI  - Protective efficacy of low-dose amantadine in adults challenged with wild-type influenza A virus
J2  - Antimicrob Agents Chemother
PY  - 1987
VL  - 31
SP  - 1470
EP  - 1473
ER  - 
TY  - JOUR
LB  - 64.
AU  - Peters, PH
AU  - Gravenstein, S
AU  - Norwood, P
AU  - De Bock, V
AU  - Van Couter, A
AU  - Gibbens, M
TI  - Long-term use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population
J2  - J Am Geriatr Soc
PY  - 2001
VL  - 49
SP  - 1025
EP  - 1031
ER  - 
TY  - JOUR
LB  - 65.
AU  - De Bock, V
AU  - Peters, P
AU  - Von Planta, T-A
AU  - Gibbens, M
AU  - Ward, P
TI  - Oral oseltamivir for prevention of influenza in the frail elderly
J2  - Clin Microbiol Infect
PY  - 2000
VL  - 6
SP  - 140
ER  - 
TY  - JOUR
LB  - 66.
AU  - Hayden, FG
AU  - Atmar, RL
AU  - Schilling, M
AU  - Johnson, C
AU  - Poretz, D
AU  - Paar, D
TI  - Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza
J2  - New Engl J Med
PY  - 1999
VL  - 341
SP  - 1336
EP  - 1343
ER  - 
TY  - JOUR
LB  - 67.
AU  - Hayden, FG
AU  - Jennings, L
AU  - Robson, R
AU  - Schiff, G
AU  - Jackson, H
AU  - Rana, B
TI  - Oral oseltamivir in human experimental influenza B infection
J2  - Antiviral Ther
PY  - 2000
VL  - 5
SP  - 205
EP  - 213
ER  - 
TY  - BOOK
LB  - 68.
AU  - Jefferson, TO
AU  - Demicheli, V
AU  - Di Pietrantonj, C
AU  - Jones, M
AU  - Rivetti, D
TI  - Neuraminidase inhibitors for preventing and treating influenza in healthy adults
PB  - Cochrane Database of Systematic Reviews
PY  - 2006
ER  - 
TY  - JOUR
LB  - 69.
AU  - Schilling, M
AU  - Povinelli, L
AU  - Krause, P
AU  - Gravenstein, M
AU  - Ambrozaitis, A
AU  - Jones, H
TI  - Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks
J2  - Vaccine
PY  - 1998
VL  - 16
SP  - 1771
EP  - 1774
ER  - 
TY  - JOUR
LB  - 70.
AU  - Monto, AS
AU  - Robinson, DP
AU  - Louise, M
AU  - James, H
AU  - Hinson, M
AU  - Elliott, MJ
TI  - Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial
J2  - JAMA
PY  - 1999
VL  - 282
SP  - 31
EP  - 35
ER  - 
TY  - JOUR
LB  - 71.
AU  - Monto, AS
AU  - Robinson, D
AU  - Griffin, AD
AU  - Edmundson, S
TI  - The effects of zanamivir on productivity in the prevention of influenza among healthy adults
J2  - J Antimicrob Chemother
PY  - 1999
VL  - 44
ER  - 
TY  - JOUR
LB  - 72.
AU  - Kaiser, L
AU  - Henry, D
AU  - Flack, NP
AU  - Keene, O
AU  - Hayden, FG
TI  - Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study
J2  - Clin Infect Dis
PY  - 2000
VL  - 30
SP  - 587
EP  - 589
ER  - 
TY  - JOUR
LB  - 73.
AU  - Hayden, F
AU  - Belshe, R
AU  - Villanueva, C
AU  - Lanno, R
AU  - Small, I
AU  - Hughes, C
TI  - Oral oseltamivir prevents the spread of influenza between children in households
J2  - Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy
PY  - 2002
VL  - 42
ER  - 
TY  - JOUR
LB  - 74.
AU  - Belshe, R
AU  - Hayden, F
AU  - Carewicz, O
AU  - Lanno, R
AU  - Martin, C
AU  - Hughes, C
TI  - Effectiveness of oral oseltamivir in preventing spread of influenza-like illness in households with proven influenza
J2  - Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy
PY  - 2001
VL  - 41
ER  - 
TY  - JOUR
LB  - 75.
AU  - LaForce, C
AU  - Man, CY
AU  - Henderson, FW
AU  - McElhaney, JE
AU  - Hampel, FC, Jr
AU  - Bettis, R
TI  - Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial
J2  - Clin Ther
PY  - 2007
VL  - 29
SP  - 1579
EP  - 1590
ER  - 
TY  - JOUR
LB  - 76.
AU  - Ambrozaitis, A
AU  - Gravenstein, S
AU  - Van Essen, G. A
AU  - Rubinstein, E
AU  - Balciuniene, L
AU  - Stikleryte, A
AU  - Crawford, C
AU  - Elliott, M
AU  - Shult, P
TI  - Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population
J2  - J of the American Medical Directors Association
PY  - 2005
VL  - 6
SP  - 367
EP  - 374
ER  - 
TY  - JOUR
LB  - 77.
AU  - Ambrozaitis,, A
AU  - Van Essen, G
AU  - Rubinstein, E
AU  - Balciuniene, L
AU  - Stikleryte, A
AU  - Gravenstein, S
TI  - Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population (NAIA3004)
J2  - J Am Geriatr Soc
PY  - 2001
VL  - 49
SP  - S130
EP  - S131
ER  - 
TY  - JOUR
LB  - 78.
AU  - Gravenstein, S
AU  - Drinka, P
AU  - Osterweil, D
AU  - Schilling, M
AU  - Krause, P
AU  - Elliott, M
TI  - Inhaled zanamivir versus rimantadine for the control of influenza in a highly vaccinated long-term care population
J2  - J Am Med Dir Assoc
PY  - 2005
VL  - 6
SP  - 359
EP  - 366
ER  - 
TY  - BOOK
LB  - 79.
AU  - Jefferson, T
AU  - Deeks, JJ
AU  - Demicheli, V
AU  - Rivetti, D
AU  - Rudin, M
TI  - Amantadine and rimantadine for preventing and treating influenza A in adults
PB  - Cochrane Database of Systematic Reviews
PY  - 2004
ER  - 
TY  - GEN
LB  - 80.
AU  - European Medicines Agency Scientific discussion
TI  - Tamiflu-H-402-II-20
PY  - 2006
ER  - 
TY  - BOOK
LB  - 81.
AU  - Matheson, NJ
AU  - Harnden, AR
AU  - Perera, R
AU  - Sheikh, A
AU  - Symmonds-Abrahams, M
TI  - Neuraminidase inhibitors for preventing and treating influenza in children
PB  - Cochrane Database of Systematic Reviews
PY  - 2007
ER  - 
TY  - JOUR
LB  - 82.
AU  - Aoki, FY
AU  - Boivin, G
AU  - Roberts, N
TI  - Influenza virus susceptibility and resistance to oseltamivir
J2  - Antiviral Ther
PY  - 2007
VL  - 12
SP  - 603
EP  - 616
ER  - 
TY  - JOUR
LB  - 83.
AU  - Hatakeyama, S
AU  - Sugaya, N
AU  - Ito, M
AU  - Yamazaki, M
AU  - Ichikawa, M
AU  - Kimura, K
AU  - Kiso, M
TI  - Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors
J2  - JAMA
PY  - 2007
VL  - 297
SP  - 1435
EP  - 1442
ER  - 
TY  - JOUR
LB  - 84.
AU  - Escuret, V
AU  - Frobert, E
AU  - Bouscambert-Duchamp, M
AU  - Sabatier, M
AU  - Grog, I
AU  - Valette, M
TI  - Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors
J2  - J Clin Virol
PY  - 2007
VL  - 41
SP  - 25
EP  - 28
ER  - 
TY  - JOUR
LB  - 85.
AU  - Kiso, M
AU  - Mitamura, K
AU  - Sakai-Tagawa, Y
AU  - Shiraishi, K
AU  - Kawakami, C
AU  - Kimura, K
TI  - Resistant influenza A viruses in children treated with oseltamivir: descriptive study
J2  - Lancet
PY  - 2004
VL  - 364
SP  - 759
EP  - 765
ER  - 
TY  - GEN
LB  - 86.
AU  - European Centre for Disease Prevention and Control
TI  - Emergence of seasonal influenza viruses type A/H1N1 with oseltamivir resistance in some European Countries at the start of the 2007–8 influenza season
PY  - 2008
ER  - 
TY  - GEN
LB  - 87.
AU  - Health Protection Agency
TI  - Oseltamivir resistance in European influenza viruses – update
PY  - 2008
ER  - 
TY  - JOUR
LB  - 88.
AU  - Cooper, NJ
AU  - Sutton, AJ
AU  - Abrams, KR
AU  - Wailoo, A
AU  - Turner, DA
AU  - Nicholson, KG
TI  - Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials
J2  - BMJ
PY  - 2003
VL  - 326
SP  - 1235
EP  - 1239
ER  - 
TY  - BOOK
LB  - 89.
AU  - Drummond, MF
AU  - Sculpher, MJ
AU  - Torrance, GW
AU  - O’Brien, BJ
AU  - Stoddart, GL
TI  - Methods for the economic evaluation of health care programmes
ET  - 3rd
CY  - New York
PB  - Oxford University Press
PY  - 2007
ER  - 
TY  - CHAP
LB  - 90.
AU  - Eddy, DM
TI  - Technology assessment: the role of mathematical modeling
A2  - Institute of Medicine
T2  - Assessing medical technology
CY  - Washington, DC
PB  - National Academy Press
PY  - 1985
SP  - 144
EP  - 153
ER  - 
TY  - JOUR
LB  - 91.
AU  - Sander, B
AU  - Hayden, FG
AU  - Gyldmark, M
AU  - Garrison, LP, Jr
TI  - Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK
J2  - Pharmacoeconomics
PY  - 2006
VL  - 24
SP  - 373
EP  - 386
ER  - 
TY  - JOUR
LB  - 92.
AU  - Risebrough, NA
AU  - Bowles, SK
AU  - Simor, AE
AU  - McGeer, A
AU  - Oh, PI
TI  - Economic evaluation of oseltamivir phosphate for postexposure prophylaxis of influenza in long-term care facilities
J2  - J Am Geriatr Soc
PY  - 2005
VL  - 53
SP  - 444
EP  - 451
ER  - 
TY  - JOUR
LB  - 93.
AU  - Scuffham, P
AU  - West, P
TI  - Economic evaluation of strategies for the control and management of influenza in Europe
J2  - Vaccine
PY  - 2002
VL  - 20
SP  - 2562
EP  - 2578
ER  - 
TY  - JOUR
LB  - 94.
AU  - Demicheli, V
AU  - Jefferson, T
AU  - Rivetti, D
AU  - Deeks, J
TI  - Prevention and early treatment of influenza in healthy adults
J2  - Vaccine
PY  - 2000
VL  - 18
SP  - 957
EP  - 1030
ER  - 
TY  - JOUR
LB  - 95.
AU  - Patriarca, PA
AU  - Arden, NH
AU  - Koplan, JP
AU  - Goodman, RA
TI  - Prevention and control of type A influenza infections in nursing homes: benefits and costs of four approaches using vaccination and amantadine
J2  - Ann Intern Med
PY  - 1987
VL  - 107
SP  - 732
EP  - 740
ER  - 
TY  - GEN
LB  - 96.
AU  - National Institute for Health and Clinical Excellence
TI  - Guide to the methods of technology appraisal
PY  - 2004
ER  - 
TY  - JOUR
LB  - 97.
AU  - Monto, AS
AU  - Gunn, RA
AU  - Bandyk, MG
AU  - King, CL
TI  - Prevention of Russian influenza by amantadine
J2  - JAMA
PY  - 1979
VL  - 241
SP  - 1003
EP  - 1007
ER  - 
TY  - JOUR
LB  - 98.
AU  - Cox, NJ
AU  - Subbarao, K
TI  - Global epidemiology of influenza: past and present
J2  - Annu Rev Med
PY  - 2000
VL  - 51
SP  - 407
EP  - 421
ER  - 
TY  - JOUR
LB  - 99.
AU  - Kaiser, L
AU  - Wat, C
AU  - Mills, T
AU  - Mahoney, P
AU  - Ward, P
AU  - Hayden, F
TI  - Oseltamivir prevents complications from influenza-related lower respiratory tract infections
J2  - ACOG Clin Rev
PY  - 2003
VL  - 8
SP  - 12
ER  - 
TY  - BOOK
LB  - 100.
AU  - Stouthard, M
AU  - Essink-Bot, M
AU  - Bonsel, G
TI  - Disability weights for diseases in the Netherlands
CY  - Rotterdam, Netherlands
PB  - Department of Public Health, Erasmus University Rotterdam
PY  - 1997
ER  - 
TY  - GEN
LB  - 101.
AU  - Department of Health and Human Services
TI  - National ambulatory medical care survey (NACMS)
PB  - National Centre for Health Statistics
PY  - 1997
ER  - 
TY  - BOOK
LB  - 102.
AU  - Curtis, L
AU  - Netten, A
TI  - Unit costs of health and social care
CY  - Canterbury
PB  - Personal Social Services Research Unit (PSSRU)
PY  - 2006
ER  - 
TY  - GEN
LB  - 103.
AU  - MIMS
TI  - The prescribing reference for general practice
PY  - 2007
ER  - 
TY  - JOUR
LB  - 104.
AU  - van Noort, SP
TI  - Gripenet: an internet-based system to monitor influenza-like illness uniformly across Europe
J2  - Euro Surveill
PY  - 2007
ER  - 
TY  - GEN
LB  - 105.
AU  - MVH Group
TI  - The measurement and valuation of health
PY  - 1994
ER  - 
TY  - GEN
LB  - 106.
AU  - Ontario Ministry of Health and Long Term Care
TI  - Ontario Ministry of Health Schedule of Benefits and Fees
PY  - 2007
ER  - 
TY  - GEN
LB  - 107.
AU  - Ontario Case Cost Initiative
TI  - Average costs per case mix group (CMG) 2000–2001
PY  - 2001
ER  - 
TY  - BOOK
LB  - 108.
AU  - Wailoo, A
AU  - Abrams, K
AU  - Turner, D
AU  - Sutton, AJ
AU  - Cooper, NJ
AU  - Nicholson, KG
TI  - Review of influenza post-exposure prophylaxis
PB  - DSU report to the National Institute for Clinical Excellence
PY  - 2003
ER  - 
TY  - BOOK
LB  - 109.
AU  - Murray, CJ
AU  - Lopez, AD
TI  - The global burden of disease: a comprehensive assessment of mortality and disabilities from diseases, injuries and risk factors in 1990 and projected to 2020
CY  - Cambridge, MA
PB  - Harvard School of Public Health
PY  - 1996
ER  - 
TY  - JOUR
LB  - 110.
AU  - Fleming, DM
TI  - The contribution of influenza to combined acute respiratory infections, hospital admissions and deaths in winter
J2  - Comm Dis Publ Health
PY  - 2000
VL  - 3
SP  - 32
EP  - 38
ER  - 
TY  - BOOK
LB  - 111.
AU  - Netten, A
AU  - Curtis, L
TI  - Unit costs of health and social care
CY  - Canterbury
PB  - Personal Social Services Research Unit (PSSRU)
PY  - 2000
ER  - 
TY  - GEN
LB  - 112.
AU  - CHKS Ltd
TI  - Hospitalisation data for England and Wales 1995–1999
PY  - 2000
ER  - 
TY  - GEN
LB  - 113.
AU  - Department of Health
TI  - Prescription cost analysis
PY  - 2000
ER  - 
TY  - GEN
LB  - 114.
AU  - Department of Health
TI  - Drug Tariff National Health Service, England and Wales
PY  - 1999
ER  - 
TY  - JOUR
LB  - 115.
AU  - Patriarca, PA
AU  - Weber, JA
AU  - Parker, RA
AU  - Orenstein, WA
AU  - Hall, WN
AU  - Kendal, AP
TI  - Risk factors for outbreaks of influenza in nursing homes
J2  - Am J Epidemiol
PY  - 1986
VL  - 124
IS  - 1
SP  - 114
EP  - 119
ER  - 
TY  - GEN
LB  - 116.
AU  - National Institute for Clinical Excellence
TI  - Guidance on the use of zanamivir, oseltamivir and amantadine for the treatment of influenza
PY  - 2003
ER  - 
TY  - BOOK
LB  - 117.
AU  - Smith, S
AU  - Demicheli, V
AU  - Pietrantonj, C
AU  - Harnden, AR
AU  - Jefferson, T
AU  - Matheson, NJ
TI  - Vaccines for preventing influenza in healthy children (review)
PB  - The Cochrane Library
PY  - 2007
ER  - 
TY  - BOOK
LB  - 118.
AU  - Jefferson, TO
AU  - Rivetti, D
AU  - Pietrantonj, C
AU  - Rivetti, A
AU  - Demicheli, V
TI  - Vaccines for preventing influenza in healthy adults (review)
CY  - The Cochrane Library
PY  - 2007
ER  - 
TY  - BOOK
LB  - 119.
AU  - Rivetti, D
AU  - Jefferson, TO
AU  - Thomas, R
AU  - Rudin, M
AU  - Rivetti, A
AU  - Pietrantonj, C
TI  - Vaccines for preventing influenza in the elderly (review)
PB  - The Cochrane Library
PY  - 2007
ER  - 
TY  - JOUR
LB  - 120.
AU  - Gross, PA
AU  - Hermogenes, AW
AU  - Sacks, HS
AU  - Lau, J
AU  - Levandowski, RA
TI  - The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature
J2  - Ann Intern Med
PY  - 1995
VL  - 123
SP  - 518
EP  - 527
ER  - 
TY  - JOUR
LB  - 121.
AU  - Nichol, KL
AU  - Margolis, KL
AU  - Lind, A
AU  - Murdoch, M
AU  - McFadden, R
AU  - Hauge, M
TI  - Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial
J2  - Ann Intern Med
PY  - 1996
VL  - 156
SP  - 1546
EP  - 1550
ER  - 
TY  - JOUR
LB  - 122.
AU  - Pitman, R
AU  - Melegaro, A
AU  - Gelb, D
AU  - Siddiqui, M
AU  - Gay, N
AU  - Edmunds, W
TI  - Assessing the burden of influenza and other respiratory infections in England and Wales
J2  - J Infect
PY  - 2007
VL  - 54
SP  - 530
EP  - 538
ER  - 
TY  - JOUR
LB  - 123.
AU  - Ross, AM
AU  - Kai, J
AU  - Salter, R
AU  - Ross, J
AU  - Fleming, DM
TI  - Presentation with influenza-like illness in general practice: implications for use of neuraminidase inhibitors
J2  - Commun Dis Publ Health
PY  - 2000
VL  - 3
SP  - 256
EP  - 260
ER  - 
TY  - JOUR
LB  - 124.
AU  - Briggs, AH
AU  - Ades, AE
AU  - Price, MJ
TI  - Probabilistic sensitivity analysis for decision trees with multiple branches: use of the Dirichlet distribution in a Bayesian framework
J2  - Med Decis Making
PY  - 2003
VL  - 23
SP  - 341
EP  - 350
ER  - 
TY  - GEN
LB  - 125.
AU  - Department of Health
TI  - NHS Reference Costs 2005–2006
PY  - 2007
ER  - 
TY  - JOUR
LB  - 126.
AU  - Oliveira, EC
AU  - Marik, PE
AU  - Colice, G
TI  - Influenza pneumonia: a descriptive study
J2  - Chest
PY  - 2001
VL  - 119
SP  - 1723
ER  - 
TY  - JOUR
LB  - 127.
AU  - Griffin, ADP
TI  - Cost-effectiveness analysis of inhaled zanamivir in the treatment of influenza A and B in high-risk patients
J2  - Pharmacoeconomics
PY  - 2001
VL  - 19
SP  - 293
EP  - 301
ER  - 
TY  - JOUR
LB  - 128.
AU  - Rothberg, MBH
TI  - Management of influenza symptoms in healthy adults: cost-effectiveness of rapid testing and antiviral therapy
J2  - J Gen Intern Med
PY  - 2003
VL  - 18
SP  - 808
EP  - 815
ER  - 
TY  - BOOK
LB  - 129.
AU  - Stratton, KR
AU  - Durch, JS
AU  - Lawrence, RS
TI  - Vaccines for the 21st century: a tool for decisionmaking
CY  - Washington, DC
PB  - National Academy Press
PY  - 2007
ER  - 
TY  - GEN
LB  - 130.
AU  - Office for National Statistics
TI  - Mortality statistics: cause
PY  - 2006
ER  - 
TY  - BOOK
LB  - 131.
AU  - Kind, P
AU  - Hardman, G
AU  - Macran, S
TI  - UK population norms for EQ-5D
PB  - Centre for Health Economics Discussion Paper Series
PY  - 1999
ER  - 
TY  - JOUR
LB  - 132.
AU  - Gupta, RK
AU  - Zhao, H
AU  - Cooke, M
AU  - Harling, R
AU  - Regan, M
AU  - Bailey, L
TI  - Public health responses to influenza in care homes: a questionnaire-based study of local health protection units
J2  - J Publ Health
PY  - 2007
VL  - 29
SP  - 88
EP  - 90
ER  - 
TY  - JOUR
LB  - 133.
AU  - Quarles, JM
AU  - Couch, RB
AU  - Cate, TR
AU  - Goswick, CB
TI  - Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza
J2  - Antiviral Res
PY  - 1981
VL  - 1
SP  - 149
EP  - 155
ER  - 
TY  - JOUR
LB  - 134.
AU  - Dolin, R
AU  - Reichman, RC
AU  - Madore, HP
AU  - Maynard, R
AU  - Linton, PN
AU  - Webber-Jones, J
TI  - A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection
J2  - New Engl J Med
PY  - 1982
VL  - 307
SP  - 580
EP  - 584
ER  - 
TY  - JOUR
LB  - 135.
AU  - Cohen, A
AU  - Togo, Y
AU  - Khakoo, R
AU  - Waldman, R
AU  - Sigel, M
TI  - Comparative clinical and laboratory evaluation of the prophylactic capacity of ribavirin, amantadine hydrochloride and placebo in induced human influenza type A
J2  - J Infect Dis
PY  - 1976
VL  - 133
IS  - Suppl
SP  - A114
EP  - A120
ER  - 
TY  - JOUR
LB  - 136.
AU  - Diggory, P
AU  - Fernandez, C
AU  - Humphrey, A
AU  - Jones, V
AU  - Murphy, M
TI  - Comparison of elderly people’s technique in using two dry powder inhalers to deliver zanamivir: randomised controlled trial
J2  - BMJ
PY  - 2001
VL  - 322
SP  - 577
EP  - 579
ER  - 
TY  - BOOK
LB  - 137.
AU  - Pocock, N
TI  - US FDA staff recommend additional neuropsychiatric warnings for oseltamivir and zanamivir
PB  - NHS National Electronic Library for Medicines
PY  - 2007
ER  -